KidneyKidney DiseasesDihydrouracil Dehydrogenase (NADP)Dihydropyrimidine Dehydrogenase DeficiencyDNA DamageKidney TubulesKidney Function TestsAlbuminuriaAcute Kidney InjuryAntineoplastic Combined Chemotherapy ProtocolsKidney CortexMucositisFluorouracilTechnetium Tc 99m Dimercaptosuccinic AcidKidney Failure, ChronicKidney GlomerulusBlood Urea NitrogenLeukopeniaCisplatinCreatinineProteinuriaAntimetabolites, AntineoplasticAntineoplastic AgentsCamptothecinKidney TransplantationDrug Administration ScheduleDiabetic NephropathiesKidney Tubules, ProximalGlomerular Filtration RateTreatment OutcomeAntineoplastic Agents, PhytogenicToxicity TestsReperfusion InjuryDose-Response Relationship, DrugLipocalinsInfusions, IntravenousGlucuronosyltransferaseNephrectomyDisease Models, AnimalRats, Sprague-DawleyNeoplasmsRenal Insufficiency, ChronicHypertensionAcute-Phase ProteinsOxidative StressTime FactorsCombined Modality TherapyBiological MarkersDrug-Related Side Effects and Adverse ReactionsRats, WistarLeucovorinMaximum Tolerated DoseNeutropeniaMice, Inbred C57BLTaxoidsSurvival AnalysisGastrointestinal DiseasesAdministration, OralThrombocytopeniaDeoxycytidineOrganoplatinum CompoundsLiverArea Under CurveCyclophosphamideBlood PressureDoxorubicinEtoposideToxicity Tests, AcuteSurvival RateDisease ProgressionPaclitaxelKidney NeoplasmsMethotrexateChronic DiseaseLung NeoplasmsNeoplasm Recurrence, LocalDisease-Free SurvivalColorectal NeoplasmsPolycystic Kidney DiseasesRetrospective StudiesNeoplasm MetastasisKidney MedullaPrevalenceAdenocarcinomaRisk FactorsProspective StudiesNeoplasm StagingRecombinant ProteinsCarcinoma, Non-Small-Cell LungChemotherapy, AdjuvantKidney CalculiPrognosisKidney Tubules, CollectingPolycystic Kidney, Autosomal DominantLethal Dose 50Breast NeoplasmsCell LineDNA RepairCell SurvivalTissue Distribution